Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States

NCT00026728 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00026728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
February 28, 2001
Completion date
December 31, 2005
Enrollment
20,169
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpesviridae infection, kaposi's sarcoma